John Maroney
Chairman,
HiLight Surgical, Inc.
John Maroney is Principal Consultant at MTCS, advising early-stage MedTech CEOs. He was CEO of Alessa Therapeutics and currently chairs Raydiant Oximetry and HiLight Surgical. He also advises Silicon Kidney and BiOxyTech Retna. Formerly, he led ForSight VISION 5 (acq. Allergan) and was a General Partner at Delphi Ventures, investing in early-stage MedTech firms like Acclarent (JNJ) and Lutonix (CR Bard). John was also CEO of EndoTex (acq. Boston Scientific). His early career included senior roles at CVIS, EP Technologies, and Abbott via Oximetrix. He serves on UC Davis’ Biomedical Engineering Advisory Board and holds a B.S. from UC Davis.
Sessions